Task: Answer the multiple choice question.
Query: Which drug exhibits a -11.297% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCN(CC)Cc1csc(C(N)=O)c1
b: CCN1C(=O)NC(c2cccnc2)C(C(=O)OC)=C1C
c: NC(=O)C1(N2CCCCC2)CCN(Cc2ccccc2)CC1
Answer: b. CCN1C(=O)NC(c2cccnc2)C(C(=O)OC)=C1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1C(=O)NC(c2cccnc2)C(C(=O)OC)=C1C
CCN1C(=O)NC(c2cccnc2)C(C(=O)OC)=C1C
methyl 3-ethyl-4-methyl-2-oxo-6-pyridin-3-yl-1,6-dihydropyrimidine-5-carboxylate